Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Landi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|December 16, 2014
Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapyDaniel Landi, Meenakshi Hegde, Nabil Ahmed
Translational Pediatrics|June 2, 2020
Current medulloblastoma subgroup specific clinical trialsEric M Thompson, David Ashley, Daniel Landi
Neuropathology : Official Journal of the Japanese Society of Neuropathology|July 25, 2018
Novel case of recurrent intraventricular atypical central neurocytoma with prominent gangliogliomatous differentiation in a 10-year-old boy with 10 years of follow upChar-Loo Tan, Daniel Landi, Herbert Fuchs, et al.
Journal of Neuro-Oncology|August 19, 2018
Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E statusEric M Thompson, Daniel Landi, David Ashley, et al.
The Clinical Journal of Pain|May 15, 2013
Differences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisisNirmish Shah, Margo Rollins, Daniel Landi, et al.
American Journal of Hematology|November 15, 2011
Complications of implantable venous access devices in patients with sickle cell diseaseNirmish Shah, Daniel Landi, Radhika Shah, et al.
Journal of Pediatric Hematology/Oncology|September 26, 2012
Report of a young girl with MYH9 mutation and review of the literatureDaniel Landi, Evelyn Lockhart, Sara E Miller, et al.
Neuro-Oncology Practice|April 4, 2022
Epidemiology of pineoblastoma in the United States, 2000-2017Kaitlyn Greppin, Gino Cioffi, Kristin A Waite, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2023
Maternal Prenatal Use of Alcohol, Tobacco, and Illicit Drugs and Associations with Childhood Cancer SubtypesCourtney E Wimberly, Natalie B Gulrajani, Jeffrey B Russ, et al.
Journal of Pediatric Hematology/Oncology|February 2, 2023
Use of Trametinib in Children and Young Adults With Progressive Low-grade Glioma and Glioneuronal TumorsEmily Hanzlik, Bridget Archambault, Mays El-Dairi, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|December 16, 2014
Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapyDaniel Landi, Meenakshi Hegde, Nabil Ahmed
Translational Pediatrics|June 2, 2020
Current medulloblastoma subgroup specific clinical trialsEric M Thompson, David Ashley, Daniel Landi
Neuropathology : Official Journal of the Japanese Society of Neuropathology|July 25, 2018
Novel case of recurrent intraventricular atypical central neurocytoma with prominent gangliogliomatous differentiation in a 10-year-old boy with 10 years of follow upChar-Loo Tan, Daniel Landi, Herbert Fuchs, et al.
Journal of Neuro-Oncology|August 19, 2018
Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E statusEric M Thompson, Daniel Landi, David Ashley, et al.
The Clinical Journal of Pain|May 15, 2013
Differences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisisNirmish Shah, Margo Rollins, Daniel Landi, et al.
American Journal of Hematology|November 15, 2011
Complications of implantable venous access devices in patients with sickle cell diseaseNirmish Shah, Daniel Landi, Radhika Shah, et al.
Journal of Pediatric Hematology/Oncology|September 26, 2012
Report of a young girl with MYH9 mutation and review of the literatureDaniel Landi, Evelyn Lockhart, Sara E Miller, et al.
Neuro-Oncology Practice|April 4, 2022
Epidemiology of pineoblastoma in the United States, 2000-2017Kaitlyn Greppin, Gino Cioffi, Kristin A Waite, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 19, 2023
Maternal Prenatal Use of Alcohol, Tobacco, and Illicit Drugs and Associations with Childhood Cancer SubtypesCourtney E Wimberly, Natalie B Gulrajani, Jeffrey B Russ, et al.
Journal of Pediatric Hematology/Oncology|February 2, 2023
Use of Trametinib in Children and Young Adults With Progressive Low-grade Glioma and Glioneuronal TumorsEmily Hanzlik, Bridget Archambault, Mays El-Dairi, et al.
Pageof 3